Devan Diwanji, MD, PhD's Publications

18F-FDG Dedicated Breast PET Complementary to Breast MRI for Evaluating Early Response to Neoadjuvant Chemotherapy.

Comparative Uptake Patterns of Radioactive Iodine and [18F]-Fluorodeoxyglucose (FDG) in Metastatic Differentiated Thyroid Cancers.

Structural dynamics of the active HER4 and HER2/HER4 complexes is finely tuned by different growth factors and glycosylation.

Structural dynamics of the active HER4 and HER2/HER4 complexes is finely tuned by different growth factors and glycosylation.

Computational pipeline provides mechanistic understanding of Omicron variant of concern neutralizing engineered ACE2 receptor traps.

Structural insights into regulation of the PEAK3 pseudokinase scaffold by 14-3-3.

An effective strategy for ligand-mediated pulldown of the HER2/HER3/NRG1β heterocomplex and cryo-EM structure determination at low sample concentrations.

An Evidence-based and Inclusive Breast Cancer Screening Strategy: Summary of Current Guidelines from the American College of Radiology and Society of Breast Imaging.

Author Correction: Structures of the HER2-HER3-NRG1β complex reveal a dynamic dimer interface.

Brain Camp: A Summer Pipeline Program to Increase Diversity in Neurosciences.

Computational pipeline provides mechanistic understanding of Omicron variant of concern neutralizing engineered ACE2 receptor traps.

Efficient expression, purification, and visualization by cryo-EM of unliganded near full-length HER3.

18F-FDG PET/CT Predicts Response to HER2-directed Neoadjuvant Therapy.

CryoEM and AI reveal a structure of SARS-CoV-2 Nsp2, a multifunctional protein involved in key host processes.

CryoEM and AI reveal a structure of SARS-CoV-2 Nsp2, a multifunctional protein involved in key host processes.

Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2.

Mutant HER2 needs mutant HER3 to be an effective oncogene.

Sentinel cells enable genetic detection of SARS-CoV-2 Spike protein.

Structures of the HER2-HER3-NRG1β complex reveal a dynamic dimer interface.

An ultra-potent synthetic nanobody neutralizes SARS-CoV-2 by locking Spike into an inactive conformation.

An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike.

Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.

More than the sum of the parts: Toward full-length receptor tyrosine kinase structures.

Structure of a cleavage-independent HIV Env recapitulates the glycoprotein architecture of the native cleaved trimer.

Correction: Minimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine Design.

Minimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine Design.

Broadly neutralizing antibody PGT121 allosterically modulates CD4 binding via recognition of the HIV-1 gp120 V3 base and multiple surrounding glycans.

Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9.